Hepatocyte growth factor: renotropic role and potential therapeutics for renal diseases.

No abstract is available for this paper.

• Publication year

  2001

• Venue

  Kidney International

• Publication date

  2001-06-01

• Fields of study

  Biology, Medicine

• Identifiers
  DOI 10.1046/J.1523-1755.2001.00717.XPMID 11380804
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Met-HGF/SF: tumorigenesis, invasion and metastasis.

  2007cited by this paper
• Hepatocyte growth factor suppresses interstitial fibrosis in a mouse model of obstructive nephropathy.

  2001cited by this paper
• Keratinocyte expression of transgenic hepatocyte growth factor affects melanocyte development, leading to dermal melanocytosis.

  2000cited by this paper
• Hepatocyte Growth Factor Overexpression in the Islet of Transgenic Mice Increases Beta Cell Proliferation, Enhances Islet Mass, and Induces Mild Hypoglycemia*

  2000cited by this paper
• Reciprocal balance of hepatocyte growth factor and transforming growth factor-beta 1 in renal fibrosis in mice.

  2000cited by this paper
• Involvement of Focal Adhesion Kinase in Hepatocyte Growth Factor-induced Scatter of Madin-Darby Canine Kidney Cells*

  2000cited by this paper
• Angiogenesis induced by hepatocyte growth factor in non-infarcted myocardium and infarcted myocardium: up-regulation of essential transcription factor for angiogenesis, ets

  2000cited by this paper
• The decrease in total collagen fibers in the liver by hepatocyte growth factor after formation of cirrhosis induced by thioacetamide.

  2000cited by this paper
• The Tyrosine Phosphatase SHP-2 Is Required for Sustained Activation of Extracellular Signal-Regulated Kinase and Epithelial Morphogenesis Downstream from the Met Receptor Tyrosine Kinase

  2000cited by this paper
• Single low-dose administration of human recombinant hepatocyte growth factor attenuates intimal hyperplasia in a balloon-injured rabbit iliac artery model.

  2000cited by this paper
• Scatter factor/hepatocyte growth factor protects against cytotoxic death in human glioblastoma via phosphatidylinositol 3-kinase- and AKT-dependent pathways.

  2000cited by this paper
• Hepatocyte growth factor in renal failure: promise and reality.

  2000cited by this paper
• Coupling of Gab1 to C-Met, Grb2, and Shp2 Mediates Biological Responses

  2000cited by this paper
• Hepatocyte growth factor in renal regeneration, renal disease and potential therapeutics.

  2000cited by this paper
• Endogenous hepatocyte growth factor ameliorates chronic renal injury by activating matrix degradation pathways.

  2000cited by this paper
• Analysis of neurotrophic effects of hepatocyte growth factor in the adult hypoglossal nerve axotomy model

  1999cited by this paper
• Renal expression of fibrotic matrix proteins and of transforming growth factor-beta (TGF-beta) isoforms in TGF-beta transgenic mice.

  1999cited by this paper
• Hepatocyte growth factor prevents endotoxin‐induced lethal hepatic failure in mice

  1999cited by this paper
• Hepatocyte growth factor promotes renal epithelial cell survival by dual mechanisms.

  1999cited by this paper
• Deleted form of hepatocyte growth factor ameliorates the mortality rate of severe thermal injury in rats.

  1999cited by this paper
• Expression of growth factors after the release of ureteral obstruction in the rat kidney

  1999cited by this paper
• Up-regulation of hepatocyte growth factor receptor: an amplification and targeting mechanism for hepatocyte growth factor action in acute renal failure.

  1999cited by this paper
• Adrenergic stimulation of hepatocyte growth factor expression.

  1999cited by this paper
• Effect of hepatocyte growth factor on tacrolimus-induced nephrotoxicity in spontaneously hypertensive rats

  1999cited by this paper
• Serum Hepatocyte Growth Factor Levels in Patients with Renal Diseases

  1999cited by this paper
• Hepatocyte growth factor/scatter factor, its molecular, cellular and clinical implications in cancer.

  1999cited by this paper
• Transforming growth factor-beta regulates tubular epithelial-myofibroblast transdifferentiation in vitro.

  1999cited by this paper
• Hepatocyte growth factor leads to recovery from alcohol-induced fatty liver in rats.

  1999cited by this paper
• Transforming growth factor-beta levels in human allograft chronic fibrosis correlate with rate of decline in renal function.

  1999cited by this paper
• Hepatocyte growth factor promotes renal epithelial cell survival by dual mechanisms.

  1999cited by this paper
• Hepatocyte growth factor and the kidney: it is not just for the liver.

  1999cited by this paper
• Acute and chronic renal effects of recombinant human TGF-beta2 in the rat.

  1999cited by this paper
• Hepatocyte growth factor gene therapy of liver cirrhosis in rats

  1999cited by this paper
• Therapeutic angiogenesis induced by human recombinant hepatocyte growth factor in rabbit hind limb ischemia model as cytokine supplement therapy.

  1999cited by this paper
• Acute and Chronic Renal Effects of Recombinant Human TGF-β2 in the Rat

  1999cited by this paper
• Effect of hepatocyte growth factor on chronic rejection in rat renal allografts.

  1999cited by this paper
• Hepatocyte growth factor induces tubulogenesis of primary renal proximal tubular epithelial cells

  1999cited by this paper
• Inhibition by Platelet-activating Factor of Src- and Hepatocyte Growth Factor-dependent Invasiveness of Intestinal and Kidney Epithelial Cells

  1998cited by this paper
• Role of growth factors in acute renal failure.

  1998cited by this paper
• Hepatocyte growth factor: Mesenchymal signal for epithelial homeostasis

  1998cited by this paper
• Negative regulation of local hepatocyte growth factor expression by angiotensin II and transforming growth factor-beta in blood vessels: potential role of HGF in cardiovascular disease.

  1998cited by this paper
• Abrogation of Fas-induced fulminant hepatic failure in mice by hepatocyte growth factor.

  1998cited by this paper
• Phosphoinositide 3-Kinase Induces Scattering and Tubulogenesis in Epithelial Cells through a Novel Pathway*

  1998cited by this paper
• Protection of Hippocampal Neurons from Ischemia-Induced Delayed Neuronal Death by Hepatocyte Growth Factor: A Novel Neurotrophic Factor

  1998cited by this paper
• Early development of chronic active hepatitis in recurrent hepatitis C virus infection after liver transplantation: association with treatment of rejection.

  1998cited by this paper
• Hepatocyte growth factor protects renal epithelial cells from apoptotic cell death.

  1998cited by this paper
• Portal branch ligation with a continuous hepatocyte growth factor supply makes extensive hepatectomy possible in cirrhotic rats

  1998cited by this paper
• Stimulation of Hepatocyte Growth Factor in Human Acute Renal Failure

  1998cited by this paper
• Two North American families with hereditary papillary renal carcinoma and identical novel mutations in the MET proto-oncogene.

  1998cited by this paper
• Interactions of transforming growth factor-beta and angiotensin II in renal fibrosis.

  1998cited by this paper
• Evidence for a functional hepatocyte growth factor receptor in human mesangial cells.

  1998cited by this paper
• Potential role of hepatocyte growth factor in the maintenance of renal structure: anti-apoptotic action of HGF on epithelial cells.

  1998cited by this paper
• Hepatocyte growth factor: mesenchymal signal for epithelial homeostasis.

  1998cited by this paper
• Membrane type 1-matrix metalloproteinase is involved in the formation of hepatocyte growth factor/scatter factor-induced branching tubules in madin-darby canine kidney epithelial cells.

  1998cited by this paper
• Growth factors and apoptosis in acute renal injury

  1998cited by this paper
• Potentiated angiogenic effect of scatter factor/hepatocyte growth factor via induction of vascular endothelial growth factor: the case for paracrine amplification of angiogenesis.

  1998cited by this paper
• Preventive effects of the deleted form of hepatocyte growth factor against various liver injuries.

  1998cited by this paper
• Hepatocyte growth factor prevents renal fibrosis and dysfunction in a mouse model of chronic renal disease.

  1998cited by this paper
• Developmental roles of HGF/SF and its receptor, the c-Met tyrosine kinase.

  1998cited by this paper
• Endothelin release by rabbit proximal tubule cells: modulatory effects of cyclosporine A, tacrolimus, HGF and EGF.

  1998cited by this paper
• Actions of hepatocyte growth factor as a local modulator in the kidney: potential role in pathogenesis of renal disease.

  1998cited by this paper
• Regenerative response in acute renal failure due to vitamin E deficiency and glutathione depletion in rats.

  1998cited by this paper
• Induction of hepatocyte growth factor in fibroblasts by tumor-derived factors affects invasive growth of tumor cells: in vitro analysis of tumor-stromal interactions.

  1997cited by this paper
• Myofibroblasts and arteriolar sclerosis in human diabetic nephropathy.

  1997cited by this paper
• Renal fibrosis: insights into pathogenesis and treatment.

  1997cited by this paper
• Hepatocyte growth factor in glycerol-induced acute renal failure.

  1997cited by this paper
• Roles of hepatocyte growth factor and its receptor Met during gastric ulcer healing in rats.

  1997cited by this paper
• Hepatic fibrosis, glomerulosclerosis, and a lipodystrophy-like syndrome in PEPCK-TGF-beta1 transgenic mice.

  1997cited by this paper
• Cellular and molecular predictors of chronic renal dysfunction after initial ischemia/reperfusion injury of a single kidney.

  1997cited by this paper
• Myofibroblast phenotypes expression in experimental renal scarring.

  1997cited by this paper
• Enhanced expression of hepatocyte growth factor/c-Met by myocardial ischemia and reperfusion in a rat model.

  1997cited by this paper
• Simultaneous or delayed administration of hepatocyte growth factor equally represses the fibrotic changes in murine lung injury induced by bleomycin. A morphologic study.

  1997cited by this paper
• Hepatocyte growth factor facilitates cartilage repair. Full thickness articular cartilage defect studied in rabbit knees.

  1997cited by this paper
• Preventive and therapeutic effects in rats of hepatocyte growth factor infusion on liver fibrosis/cirrhosis

  1997cited by this paper
• Germline and somatic mutations in the tyrosine kinase domain of the MET proto-oncogene in papillary renal carcinomas

  1997cited by this paper
• Renal tubular hyperplasia, polycystic disease, and glomerulosclerosis in transgenic mice overexpressing hepatocyte growth factor/scatter factor.

  1997cited by this paper
• Activating mutations for the met tyrosine kinase receptor in human cancer.

  1997cited by this paper
• Diverse tumorigenesis associated with aberrant development in mice overexpressing hepatocyte growth factor/scatter factor.

  1997cited by this paper
• Effect of bacterial lipopolysaccharide on endothelin-1 production in human vascular endothelial cells.

  1997cited by this paper
• The role of the B7 costimulatory pathway in experimental cold ischemia/reperfusion injury.

  1997cited by this paper
• Transforming growth factor-beta in human glomerular injury.

  1997cited by this paper
• Hepatocyte growth factor (HGF) as a tissue organizer for organogenesis and regeneration.

  1997cited by this paper
• Transforming growth factor-β in human glomerular injury

  1997cited by this paper
• Hepatocyte growth factor/scatter factor is an axonal chemoattractant and a neurotrophic factor for spinal motor neurons.

  1996cited by this paper
• Relationship between alpha-smooth muscle actin expression and fibrotic changes in human kidney.

  1996cited by this paper
• Activation of Hepatocyte Growth Factor in the Injured Tissues Is Mediated by Hepatocyte Growth Factor Activator (*)

  1996cited by this paper
• Antifibrogenic effect of a deletion variant of hepatocyte growth factor on liver fibrosis in rats

  1996cited by this paper
• Hepatocyte growth factor in lung morphogenesis and tumor invasion: role as a mediator in epithelium-mesenchyme and tumor-stroma interactions

  1996cited by this paper
• Interaction between Gab1 and the c-Met receptor tyrosine kinase is responsible for epithelial morphogenesis

  1996cited by this paper
• Preventive effect of hepatocyte growth factor on acute side effects of cyclosporin A in mice.

  1996cited by this paper
• Serum HGF levels in acute renal rejection after living related renal transplantation

  1996cited by this paper
• In vivo mitogenic action of HGF on lung epithelial cells: pulmotrophic role in lung regeneration.

  1996cited by this paper
• Emerging multipotent aspects of hepatocyte growth factor.

  1996cited by this paper
• Expression of hepatocyte growth factor, transforming growth factor α, and transforming growth factor β 1 messenger RNA in various human liver diseases and correlation with hepatocyte proliferation

  1996cited by this paper
• HGF receptor associates with the anti‐apoptotic protein BAG‐1 and prevents cell death.

  1996cited by this paper
• Transgenic mice with increased plasma levels of TGF-beta 1 develop progressive renal disease.

  1996cited by this paper
• The many faces of hepatocyte growth factor: from hepatopoiesis to hematopoiesis

  1995cited by this paper
• Placental defect and embryonic lethality in mice lacking hepatocyte growth factor/scatter factor

  1995cited by this paper
• Novel function of prostaglandins as inducers of gene expression of HGF and putative mediators of tissue regeneration.

  1995cited by this paper
• Hepatic expression of mature transforming growth factor beta 1 in transgenic mice results in multiple tissue lesions.

  1995cited by this paper

• Cell-free regenerative medicine: identifying the best source of mesenchymal stem cells for skin therapy in Systemic Sclerosis

  2025cites this paper
• Immunohistochemical distribution of HGF, IGF-I, FGF-2, and TGF-α in kidney and liver tissues of geese (Anser anser) during hatching and post-hatching periods

  2025cites this paper
• Hepatocyte Growth Factor-Modified Dental Pulp Stem Cells Potentially Regulate Novel Renal Fibrosis-Associated Gene via PI3K/AKT/GSK3β Pathway to Alleviate Renal Fibrosis

  2025cites this paper
• Deciphering Intercellular Communication of the Immune Landscape within Autosomal Dominant Polycystic Kidney Disease Microenvironment at Single-Cell Resolution

  2025cites this paper
• Engineering Multilayered Hepatic Cell Sheet Model Using Oxygen-Supplying MeHA/CPO Hydrogel

  2025cites this paper
• The Role of Cytokines and Chemokines as Biomarkers of Disease Activity in Idiopathic Nephrotic Syndrome in Children

  2025cites this paper
• Ginger (Zingiber officinale Roscoe) Bioactive Components: Potential Resources for Kidney Health

  2025cites this paper
• Serum Hepatocyte Growth Factor Concentration Correlates with Albuminuria in Individuals with Optimal Blood Pressure and Untreated Arterial Hypertension

  2024cites this paper
• Improvement effects of transplanting pancreatic islet that previously incubated with biomaterials on the diabetic nephropathy in STZ- diabetic rats

  2024cites this paper
• Cancer Metastases to the Liver: Mechanisms of Tumor Cell Colonization

  2024cites this paper
• Savolitinib: A Promising Targeting Agent for Cancer

  2023cites this paper
• The Crosstalk between Mesenchymal Stromal/Stem Cells and Hepatocytes in Homeostasis and under Stress

  2023cites this paper
• The injury-induced transcription factor SOX9 alters the expression of LBR, HMGA2, and HIPK3 in human kidney.

  2022cites this paper
• Construction of HGF-Displaying Yeast by Cell Surface Engineering

  2022cites this paper
• Recent advances in the therapeutic efficacy of hepatocyte growth factor gene‐modified mesenchymal stem cells in multiple disease settings

  2022cites this paper
• Therapeutic Strategies for Ovarian Cancer in Point of HGF/c-MET Targeting

  2022cites this paper
• Progress and Current Limitations of Materials for Artificial Bile Duct Engineering

  2021cites this paper
• The levels of soluble cMET ectodomain in the blood of patients with ovarian cancer are an independent prognostic biomarker

  2021cites this paper
• Improved bladder contractility after transplantation of human mesenchymal stem cells overexpressing hepatocyte growth factor into underactive bladder from bladder outlet obstruction models of rats

  2021cites this paper
• Prognostic relevance of longitudinal HGF levels in serum of patients with ovarian cancer

  2021cites this paper
• E4 engages uPAR and enolase-1 and activates urokinase to exert antifibrotic effects

  2021cites this paper
• Telocytes of the male urogenital system: Interrelationships, possible functions, and pathological implications

  2021cites this paper
• Met and Cxcr4 cooperate to protect skeletal muscle stem cells against inflammation-induced damage during regeneration

  2021cites this paper
• CDCP1 promotes compensatory renal growth by integrating Src and Met signaling

  2021cites this paper
• Immunogenomic Landscape Analysis of Prognostic Immune-Related Genes in Hepatocellular Carcinoma

  2021cites this paper
• The hepatocyte growth factor/c-met pathway is a key determinant of the fibrotic kidney local microenvironment

  2021cites this paper
• HGF-mediated Up-regulation of PHLDA2 Is Associated With Apoptosis in Gastric Cancer

  2021cites this paper
• DDDT_A_264898 4053..4067

  2020cites this paper
• Tissue engineering of the kidney

  2020cites this paper
• Dsg2-mediated c-Met activation in anaplastic thyroid cancer motility and invasion.

  2020cites this paper
• DDDT_A_264898 4053..4067

  2020cites this paper
• MET targeting: time for a rematch

  2020cites this paper
• Integrated Network Pharmacology Analysis and Pharmacological Evaluation to Explore the Active Components and Mechanism of Abelmoschus manihot (L.) Medik. on Renal Fibrosis

  2020cites this paper
• The selective c-Met inhibitor capmatinib offsets cisplatin-nephrotoxicity and doxorubicin-cardiotoxicity and improves their anticancer efficacies.

  2020cites this paper
• Tubule-derived lactate is required for fibroblast activation in acute kidney injury.

  2020cites this paper
• Potential targeted therapy and diagnosis based on novel insight into growth factors, receptors, and downstream effectors in acute kidney injury and acute kidney injury-chronic kidney disease progression

  2020cites this paper
• Mesenchymal Stem Cells as Therapeutic Agents and Novel Carriers for the Delivery of Candidate Genes in Acute Kidney Injury

  2020cites this paper
• HGF induces protective effects in α-naphthylisothiocyanate-induced intrahepatic cholestasis by counteracting oxidative stress.

  2020cites this paper
• Fibroblast mTOR/PPARγ/HGF axis protects against tubular cell death and acute kidney injury

  2019cites this paper
• Hypoxia-preconditioned MSCs Have Superior Effect in Ameliorating Renal Function on Acute Renal Failure Animal Model

  2019cites this paper
• CUB domain-containing protein 1 controls HGF responses by integrating Src and Met–STAT3 signaling

  2019cites this paper
• Remodeling of Glycosaminoglycans During Differentiation of Adult Human Bone Mesenchymal Stromal Cells Toward Hepatocytes

  2019cites this paper
• Combination of Nonwoven Filters and Mesenchymal Stem Cells Reduced Glomerulosclerotic Lesions in Rat Chronic Kidney Disease Models

  2019cites this paper
• Cerebro- and renoprotective activities through platelet-derived biomaterials against cerebrorenal syndrome in rat model.

  2019cites this paper
• LC3C-Mediated Autophagy Selectively Regulates the Met RTK and HGF-Stimulated Migration and Invasion.

  2019cites this paper
• CDCP1 controls compensatory renal growth by integrating Src and Met signaling

  2019cites this paper
• Oncogene addiction as a foundation of targeted cancer therapy: The paradigm of the MET receptor tyrosine kinase.

  2019cites this paper
• Transforming growth factor β (TGFβ) and related molecules in chronic kidney disease (CKD).

  2019cites this paper
• Cabozantinib: Multi-kinase Inhibitor of MET, AXL, RET, and VEGFR2.

  2018cites this paper
• Hepatocyte growth factor alleviates hepatic insulin resistance and lipid accumulation in high‐fat diet‐fed mice

  2018cites this paper
• Renoprotective Effect of Platelet-Rich Plasma on Cisplatin-Induced Nephrotoxicity in Rats

  2018cites this paper
• Small Molecules in Oncology

  2018cites this paper
• Light and Electron Microscope Study on the Effect of Platelet-Rich Plasma in Induced Renal Ischaemia-Reperfusion Injury in the Renal Cortex of Adult Male Albino Rats

  2018cites this paper
• Updates on the hepatocyte growth factor/c-Met axis in hepatocellular carcinoma and its therapeutic implications

  2018cites this paper
• Possible protective effect of platelet‐rich plasma on a model of cisplatin‐induced nephrotoxicity in rats: A light and transmission electron microscopic study

  2018cites this paper
• Nephrotoxicity Induced by Cisplatin Intake in Experimental Rats and Therapeutic Approach of Using Mesenchymal Stem Cells and Spironolactone

  2018cites this paper
• Bioactive Compounds for the Treatment of Renal Disease

  2018cites this paper
• Antifibrotic Effects of Hepatocyte Growth Factor on Endothelial-to-Mesenchymal Transition via Transforming Growth Factor-Beta1 (TGF-β1)/Smad and Akt/mTOR/P70S6K Signaling Pathways

  2018cites this paper
• Implication du facteur développemental Lim1, un nouvel oncogène, dans le cancer du rein humain avancé

  2017cites this paper
• Targeting the hepatocyte growth factor/Met pathway in cancer.

  2017cites this paper
• Inflammation, Wound Healing, and Fibrosis

  2017cites this paper
• Vanillin as a new modulator candidate for renal injury induced by cisplatin in experimental rats

  2017cites this paper
• Hepatocyte growth factor/MET in cancer progression and biomarker discovery

  2017cites this paper
• The plusses and minuses of bone marrow-derived mesenchymal stem cells in the treatment of liver cirrhosis

  2017influential citation
• High glucose induces HGF-independent activation of Met receptor in human renal tubular epithelium

  2017influential citation
• Challenges and future of biomarker tests in the era of precision oncology: Can we rely on immunohistochemistry (IHC) or fluorescence in situ hybridization (FISH) to select the optimal patients for matched therapy?

  2017cites this paper
• Transforming Growth Factor-beta ( TGF-β ) との 拮抗作用によるHepatocyte Growth Factor ( HGF )

  2017cites this paper
• Title Repair of segmental bone defects in rabbit tibia promoted by a complex ofβ-tricalcium phosphate and hepatocyte growth factor

  2017cites this paper
• Inflammation and Cancer

  2017cites this paper
• Hepatocyte growth factor (HGF) and hemodialysis: physiopathology and clinical implications

  2016cites this paper
• Animal Models of Systemic Sclerosis

  2016cites this paper
• oxidative stress is mediated through the interplay Suppression of HGF receptor gene expression by

  2016cites this paper
• C-Met as a Molecular Marker for Esophageal Squamous Cell Carcinoma and Its Association with Clinical Outcome

  2016cites this paper
• 10-DHGD ameliorates cisplatin-induced nephrotoxicity in rats.

  2016cites this paper
• and endothelial cells in cocultures Cross talk between primary human renal tubular cells

  2016cites this paper
• Effects of Platelet-Rich Plasma on Kidney Regeneration in Gentamicin-Induced Nephrotoxicity

  2016cites this paper
• Preclinical and clinical evaluation of MET functions in cancer cells and in the tumor stroma

  2016cites this paper
• Expression of hypoxia‐inducible factor‐1α and hepatocyte growth factor in development of fibrosis in the transplanted kidney

  2015cites this paper
• Histamine deficiency exacerbates myocardial injury in acute myocardial infarction through impaired macrophage infiltration and increased cardiomyocyte apoptosis

  2015cites this paper
• The Role of Tyrosine Kinase Receptors in Peritoneal Fibrosis

  2015cites this paper
• Hepatocyte Growth Factor-20140423

  2015cites this paper
• The low levels of circulating hepatocyte growth factor in nephrolithiasis cases: independent from gene polymorphism

  2015cites this paper
• Roles of Proteoglycans and Glycosaminoglycans in Wound Healing and Fibrosis

  2015cites this paper
• Synergistic Effects of Combining Anti-Midkine and Hepatocyte Growth Factor Therapies Against Diabetic Nephropathy in Rats

  2015cites this paper
• Biology of MET: a double life between normal tissue repair and tumor progression.

  2015cites this paper
• Effect of Bioconjugation of Oligodeoxynucleotides with Lutein on N-nitrosodimethylamine Induced Fibrosis in Cultured Human Retinal Pigment Epithelial Cells

  2015cites this paper
• HGF expression induced by HIF‐1α promote the proliferation and tube formation of endothelial progenitor cells

  2015cites this paper
• Targeting the MeT receptor tyrosine kinase in non-small cell lung cancer: emerging role of tivantinib

  2014cites this paper
• Mesenchymal stromal cells reset the scatter factor system and cytokine network in experimental kidney transplantation

  2014cites this paper
• Targeting the MeT receptor tyrosine kinase in non-small cell lung cancer: emerging role of tivantinib

  2014cites this paper
• Inflammation, advancing age and nutrition

  2014cites this paper
• Targeting the MeT receptor tyrosine kinase in non-small cell lung cancer : emerging role of tivantinib eberechi

  2014cites this paper
• Hepatocyte Growth Factor

  2014cites this paper
• Protective effect and localization by optical imaging of human renal CD133+ progenitor cells in an acute kidney injury model

  2014cites this paper
• Protective effect and localization by optical imaging of human renal CD133 + progenitor cells in an acute kidney

  2014cites this paper
• Cabozantinib: a MET, RET, and VEGFR2 tyrosine kinase inhibitor.

  2014cites this paper
• Trophokines: Novel Therapy for Senescence-Related Fibrosis

  2014cites this paper
• Treatment of aging vocal folds: novel approaches

  2014cites this paper
• Protection against radiation-induced hematopoietic damage in bone marrow by hepatocyte growth factor gene transfer

  2014cites this paper
• Overexpression of c-Met and CD44v6 Receptors Contributes to Autocrine TGF-β1 Signaling in Interstitial Lung Disease*

  2014cites this paper